[Studies on cardiovascular drugs. XII. Pharmacological properties of 1-tert-butylamino-3-(o-(tetrahydrofurfuryloxy)phenoxy)-2-propanol hydrochloride (Y-6124)].
D000433:1-Propanol / Q000494:pharmacology; D000319:Adrenergic beta-Antagonists / Q000494:pharmacology*; D000605:Amino Alcohols / Q000494:pharmacology*; D000779:Anesthetics, Local; D000818:Animals; D002082:Butylamines / Q000494:pharmacology; D005230:Fatty Acids, Nonesterified / Q000097:blood; D005663:Furans / Q000494:pharmacology; D006168:Guinea Pigs; D006943:Hyperglycemia / Q000188:drug therapy; D066298:In Vitro Techniques; D050356:Lipid Metabolism; D008297:Male; D051379:Mice; D011817:Rabbits; D051381:Rats
D000319:Adrenergic beta-Antagonists; D000605:Amino Alcohols; D000779:Anesthetics, Local; D002082:Butylamines; D005230:Fatty Acids, Nonesterified; D005663:Furans; D000433:1-Propanol